EARLY HCV VIRAL KINETICS UNDER DAAs MAY OPTIMIZE DURATION OF THERAPY IN PATIENTS WITH COMPENSATED CIRRHOSIS

BACKGROUND AND AIMS: Detailed hepatitis C virus (HCV) kinetics modeling is scarce in patients with advanced liver disease receiving direct-acting antivirals (DAAs). Due to budget restrictions, patients and health systems would benefit from the shortest possible treatment course. We investigated whet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Int
Autors principals: Gambato, Martina, Canini, Laetitia, Lens, Sabela, Graw, Frederik, Perpiñan, Elena, Londoño, Maria-Carlota, Uprichard, Susan L., Mariño, Zoe, Reverter, Enric, Bartres, Concepcio, González, Patricia, Pla, Anna, Costa, Josep, Burra, Patrizia, Cotler, Scott J., Forns, Xavier, Dahari, Harel
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483833/
https://ncbi.nlm.nih.gov/pubmed/30499631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars